Allianz Asset Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,210
Closed -$538K 2488
2021
Q1
$538K Sell
6,210
-34
-0.5% -$2.99K ﹤0.01% 1868
2020
Q4
$526K Sell
6,244
-247
-4% -$21.1K ﹤0.01% 1621
2020
Q3
$518K Sell
6,491
-234
-3% -$19.4K ﹤0.01% 1598
2020
Q2
$596K Buy
6,725
+329
+5% +$29.5K ﹤0.01% 1999
2020
Q1
$602K Sell
6,396
-261
-4% -$24.3K ﹤0.01% 1979
2019
Q4
$718K Buy
6,657
+575
+9% +$58.3K ﹤0.01% 2314
2019
Q3
$583K Buy
6,082
+389
+7% +$36.2K ﹤0.01% 2319
2019
Q2
$545K Buy
5,693
+9
+0.2% +$758 ﹤0.01% 2317
2019
Q1
$502K Buy
5,684
+446
+9% +$39.2K ﹤0.01% 2325
2018
Q4
$435K Sell
5,238
-732
-12% -$64.5K ﹤0.01% 2318
2018
Q3
$562K Sell
5,970
-315
-5% -$30.1K ﹤0.01% 2358
2018
Q2
$692K Sell
6,285
-540
-8% -$56.4K ﹤0.01% 2317
2018
Q1
$675K Sell
6,825
-105
-2% -$9.37K ﹤0.01% 2318
2017
Q4
$564K Buy
+6,930
New +$541K ﹤0.01% 2383

Other funds holding UTMD

Allianz Asset Management's UTMD Position: Q2 2021 in Review

Allianz Asset Management sold out of Utah Medical Products (UTMD) in Q2 2021, closing a stake of 6,210 shares — an estimated $538K sold.

Allianz Asset Management first reported a position in UTMD in Q4 2017 and held it in 14 quarters. The position peaked at $718K in Q4 2019. 68 funds tracked by Wall St. Rank hold UTMD as of Q2 2021.

  • Allianz Asset Management reported no remaining Utah Medical Products position as of Q2 2021 after selling out during the quarter.
  • Allianz Asset Management sold 6,210 Utah Medical Products shares in Q2 2021, an estimated $538K.
  • Allianz Asset Management first reported a position in Utah Medical Products in Q4 2017 and held it in 14 quarters.
  • Allianz Asset Management's Utah Medical Products position peaked at $718K in Q4 2019.
  • 68 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2021.

Based on Allianz Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.